Additionally, ASPH co-expresses with PDL1 and PVR in the epithelium of gallbladder cancer, thereby achieving immune escape through common immune checkpoint pathways such as PD1 (30) and TIGIT (31). Here, PVR is linked to gallbladder cancer.